Joyeux M, Baxter G F, Thomas D L, Ribuot C, Yellon D M
The Hatter Institute for Cardiovascular Studies, University College London Hospitals & Medical School, London, UK.
J Mol Cell Cardiol. 1997 Dec;29(12):3311-9. doi: 10.1006/jmcc.1997.0556.
Heat stress (HS) is known to protect against mechanical dysfunction and myocardial necrosis in myocardial ischemia-reperfusion models both in vivo and in vitro. However, the mechanisms involved in this form of cardioprotection remain unclear. Protein kinase C (PKC) and tyrosine kinase activation have both been shown to be involved in the delayed phase of protection following ischemic preconditioning, a phenomenon which appears to be analogous to HS-induced protection. Therefore, we investigated the role of PKC and tyrosine kinase in HS-induced resistance to myocardial infarction, in the isolated rat heart. The selective inhibitors chelerythrine (Che) and genistein (Gen) were used to inhibit PKC and tyrosine kinase, respectively. Rats were treated with Che (5 mg/kg, i.p.) or Gen (5 mg/kg, i.p.) or vehicle before they were either heat stressed (42 degrees C for 15 min) or sham anesthetized. Twenty-four h later their hearts were isolated, retrogradely perfused, and subjected to 35-min occlusion of the left coronary artery followed by 120-min of reperfusion. Infarct-to-risk ratio was significantly reduced in HS (19.9+/-1.1%) compared to sham (43.1+/-1.1%) hearts. This reduction in infarct size was abolished in chelerythrine-treated groups (43.8+/-1.9% in HS+Che v 44.9+/-2.0% in sham+Che), but was conserved in genistein-treated groups (17.7+/-0.9% in HS+Gen v 36.4+/-2.8% in sham+Gen). In order to confirm that genistein at this dose was effectively inhibiting tyrosine kinase activity, we observed the ability of the agent to prevent the hypoglycemic responses to insulin in a separate group of anesthetised rats receiving an i.v. insulin infusion. Western blot analysis of the myocardial hsp72 showed a HS-induced increase of this protein, which was modified by neither the PKC inhibitor, chelerythrine, nor the tyrosine kinase inhibitor, genistein. We conclude that the activation of PKC, but not of tyrosine kinase, appears to play a role in the functional cardioprotection associated with the heat stress response. Although protection appears to be dissociated from induction of hsp72, further work is required to explore the importance of hsp72 phosphorylation to cytoprotective activity of the protein.
已知热应激(HS)在体内和体外心肌缺血再灌注模型中均可防止机械功能障碍和心肌坏死。然而,这种心脏保护形式所涉及的机制仍不清楚。蛋白激酶C(PKC)和酪氨酸激酶的激活均已被证明参与缺血预处理后的延迟保护阶段,这一现象似乎类似于HS诱导的保护。因此,我们在离体大鼠心脏中研究了PKC和酪氨酸激酶在HS诱导的心肌梗死抵抗中的作用。分别使用选择性抑制剂白屈菜红碱(Che)和染料木黄酮(Gen)抑制PKC和酪氨酸激酶。在对大鼠进行热应激(42℃,15分钟)或假麻醉之前,用Che(5mg/kg,腹腔注射)或Gen(5mg/kg,腹腔注射)或赋形剂处理大鼠。24小时后,分离出它们的心脏,逆行灌注,并对左冠状动脉进行35分钟的闭塞,随后再灌注120分钟。与假手术(43.1±1.1%)心脏相比,HS组(19.9±1.1%)的梗死与危险比显著降低。在白屈菜红碱处理组中,梗死面积的这种减少被消除(HS+Che组为43.8±1.9%,假手术+Che组为44.9±2.0%),但在染料木黄酮处理组中得以保留(HS+Gen组为17.7±0.9%,假手术+Gen组为36.4±2.8%)。为了证实该剂量的染料木黄酮有效抑制酪氨酸激酶活性,我们在另一组接受静脉胰岛素输注的麻醉大鼠中观察了该药物预防胰岛素低血糖反应的能力。心肌hsp72的蛋白质印迹分析显示,HS诱导该蛋白增加,PKC抑制剂白屈菜红碱和酪氨酸激酶抑制剂染料木黄酮均未对其产生影响。我们得出结论,PKC的激活而非酪氨酸激酶的激活似乎在与热应激反应相关的功能性心脏保护中起作用。虽然保护作用似乎与hsp72的诱导无关,但需要进一步研究以探讨hsp72磷酸化对该蛋白细胞保护活性的重要性。